NICE: NHS Will Not Fund Donanemab For Alzheimer’s ...Middle East

Medscape - News
The MHRA has approved the drug for the treatment of Alzheimer’s disease, but NICE said the relatively small benefit it provided to patients did not represent value for money. Medscape News UK

Hence then, the article about nice nhs will not fund donanemab for alzheimer s was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NICE: NHS Will Not Fund Donanemab For Alzheimer’s )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News